secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001185185-23-000887
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma shareholders pass all five proposals at 2023 annual meeting
----------------------------------------------------------------------

- Claudia Grimaldi elected Class A director with 14.7M for, 1.4M withheld, 11M broker non-votes.
- Ratified Manohar Chowdhry & Associates as auditor for FY2024: 26.9M for, 163K against.
- Approved grant of 3M common shares to employees, advisors, directors; 14.3M for.
- Say-on-pay approved (15.3M for); frequency set at every three years (13.1M for 3 yrs).
- Board adopts triennial advisory vote on executive compensation going forward.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/0001185185-23-000887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518523000887/igcpharma20230821_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-23-000887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer